LOGOLOGOLOGOLOGO
  • About us
    • What we do
    • Who we are
      • Governance
      • Staff
      • Vacancies
  • Members
    • EuropaBio Members
    • About Membership
  • How we work
    • Healthcare Biotechnology Council
      • Patient BioForum
      • Study – Impact of the EU’s General Pharmaceutical Legislation
    • Industrial Biotechnology Council
      • EFIB
      • Microorganisms
    • National Associations Council
    • SME Platform
    • Biomanufacturing Platform
      • Biotechnology in our Lives
  • Activities
    • 25 Years of Innovation
    • The EU Biotech Act
    • European Biotech Week
    • EU Projects
      • PRIMED Project
      • APROVALS Project
  • News & Events
    • News
    • Events
  • Library
Become a member
✕
  • 30/11/2022

    EuropaBio presents EFIB Vilnius Statement to European policymakers
  • 28/11/2022

    Enabling Patient Access to Transformational Therapeutic Innovations: Modernising the EU’s Cross-Border Healthcare Framework
  • 25/11/2022

    The time to act is now! Biotechnology for global transformation
  • 23/11/2022

    Innovation, Investment, and Excellence for Healthcare Biotechnology: Achieving a competitive environment in Europe | EuropaBio Healthcare BioForum, October 2022
  • 16/11/2022

    Policy Proposal for New Genomic Techniques – Joint Letter to the EU Vice-President Frans Timmermans and the EU Commissioner Stella Kyriakides
  • 14/11/2022

    A new initiative for building a more competitive Europe: EuropaBio announces Biomanufacturing Platform
  • 28/10/2022

    Europe’s potential in advanced Biomanufacturing at the centre of EFIB 2022 discussions
  • 24/10/2022

    European Biotech Week 2022: Bringing Biotech to Local Communities
  • 20/10/2022

    Ensuring the full potential of EHDS: Stakeholders’ recommendations on how to make the digital transformation a success across Europe
  • 19/10/2022

    #EFIB2022:  Industrial biotechnology community comes together in Vilnius next week
  • 11/10/2022

    Factsheet – Vision for Europe: Excellence
  • 11/10/2022

    Factsheet – Vision for Europe: Investment
  • 11/10/2022

    Factsheet – Vision for Europe: Innovation
  • 06/10/2022

    EuropaBio celebrates its inaugural Healthcare BioForum
  • 03/10/2022

    Vision for Europe: Innovation, Investment, Excellence | Claire Skentelbery, EuropaBio
  • 30/09/2022

    Collaboration, expertise, and infrastructure: key ingredients for gene therapy to thrive in Europe
  • 25/09/2022

    European Biotech Week 2022 starts today!
  • 21/09/2022

    Vision for Europe:Innovation, Investment, Excellence | Yordan Aleksandrov, Pfizer
  • 21/09/2022

    Vision for Europe: Innovation, Investment, Excellence | Tineke Van hooland, bio.be/essenscia
  • 21/09/2022

    Vision for Europe: Innovation, Investment, Excellence | Thomas Bols, PTC Therapeutics
Prev page
12345...16
Next page
EBIO-white

EuropaBio represents corporate and associate members across sectors, plus national and regional biotechnology associations which, in turn, represent over 5000 biotech companies, 4600 out of them are SMEs.

Contact us

Extra links

Members
Staff
Privacy policy
Legal & cookies
Events
Newsroom

Become a member

Media pack

© 2025 Europabio. All Rights Reserved. Designed by EYAS
Become a member

Algal Omega 3

Algal Omega-3 is an innovative feed product for aquaculture. It reduces the impact on climate change by 30-40% compared to fish oil and saves 60 tons of wild fish for every ton of Algal Omega-3 used.

Cheese

Cheese is a vegetarian product thanks to biotechnology. Biotechnology is also essential to produce lactose- or cholesterol-free cheese, as well as alternative proteins.

Clothes

Clothes made from alternative fibres produced by microorganisms can be 8x stronger than steel, 100% recyclable, biodegradable and replace fossil-fuel based or resource-intensive textiles.

Vitamin B2

The biomanufacturing of Vitamin B2 led to the reduction of 75% of fossil raw materials and 50% operating costs, compared to the chemical process. Vitamin B2 is used in the food, feed or healthcare sectors.

Detergents

Enzymes and biosurfactancts are alternative ingredients that improve the performance of detergents, while leading to water and energy savings and reductions in CO2 emissions and water toxicity.

Insulin

Insulin is one of the most widely known biopharmaceutical. Biotechnology revolutionised its manufacturing process and led to the development of new types of insulin through r-DNA technology.